Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Astrazeneca PLC

Symbol: AZN     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
4.72%
Current Price
$40.27
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-09 15:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
5,491,000,000
5,491,000,000
1,129,000,000
4,362,000,000
3,265,000,000
1,097,000,000
593,000,000
13,649,000,000
61,055,000,000
49,026,000,000
10,483,000,000
3,926,000,000
3,719,000,000
4,958,000,000
21,578,000,000
-757,000,000
-387,000,000
 
1,266,000,000

Financials 2018

Update: 2019-06-09 15:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
6,417,000,000
6,417,000,000
1,637,000,000
4,780,000,000
5,580,000,000
-800,000,000
1,034,000,000
15,591,000,000
60,651,000,000
46,607,000,000
12,468,000,000
-
1,754,000,000
5,554,000,000
19,113,000,000
-
-
 
2,012,000,000

Q 3

2018-09-30
5,340,000,000
5,340,000,000
1,153,000,000
4,187,000,000
3,336,000,000
851,000,000
431,000,000
13,108,000,000
61,443,000,000
47,906,000,000
11,936,000,000
-
2,491,000,000
4,228,000,000
20,913,000,000
-
-
 
1,279,000,000

Q 2

2018-06-30
5,155,000,000
5,155,000,000
1,012,000,000
4,143,000,000
3,380,000,000
763,000,000
350,000,000
12,449,000,000
61,344,000,000
47,072,000,000
12,645,000,000
-
4,215,000,000
3,777,000,000
19,667,000,000
-
-
 
1,362,000,000

Q 1

2018-03-31
5,178,000,000
5,178,000,000
1,134,000,000
4,044,000,000
3,348,000,000
696,000,000
340,000,000
-
-
n.a.
-
-
-
-
-
-
-
 
1,279,000,000

Financials 2017

Update: 2019-06-09 15:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
5,777,000,000
5,777,000,000
1,225,000,000
4,552,000,000
5,251,000,000
-699,000,000
1,301,000,000
13,150,000,000
63,354,000,000
46,712,000,000
14,960,000,000
-
2,247,000,000
4,461,000,000
17,807,000,000
-
-
 
1,551,000,000